Cellectis cellectis.com


Public list: BIO 2016 (619) Synthetic Biology (153) Pharma Startups (6570) Cancer Therapeutics (1180)

Cellectis is a gene-editing company, employing proprietary technologies to develop best-in-class products in the emerging field of immuno-oncology. The company's product candidates, based on gene-edited T-cells that express chimeric antigen receptors, or CARs, seek to harness the power of the immune system to target and eradicate cancers. Cellectis believes that CAR-based immunotherapy is one of the most promising areas of cancer research, representing a new paradigm for cancer treatment. The co...Show all

Cellectis is a gene-editing company, employing proprietary technologies to develop best-in-class products in the emerging field of immuno-oncology. The company's product candidates, based on gene-edited T-cells that express chimeric antigen receptors...Show all

Company (IPO / Went public)

Phone: 33181691600

Fax:

8 rue de la Croix Jarry

Paris, 75013
France

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Cellectis $196.7M Mar 25, 2015

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Cellectis Jobs

jobs by Indeed job
						search
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.